HomeMARKSANS • NSE
add
Marksans Pharma Ltd
Previous close
₹184.29
Day range
₹176.82 - ₹187.50
Year range
₹171.00 - ₹358.70
Market cap
80.70B INR
Avg Volume
1.82M
P/E ratio
23.06
Dividend yield
0.45%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 6.20B | 4.97% |
Operating expense | 2.81B | 27.31% |
Net income | 583.17M | -34.29% |
Net profit margin | 9.41 | -37.39% |
Earnings per share | — | — |
EBITDA | 966.77M | -23.61% |
Effective tax rate | 24.02% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.06B | 0.77% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 24.89B | — |
Shares outstanding | 452.07M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | 7.35% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 583.17M | -34.29% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1992
Website
Employees
1,840
